Parabilis Medicines
PBLS----
Parabilis Medicines (PBLS)
Parabilis Medicines, Inc. operates as a clinical-stage biopharmaceutical company focused on developing helical peptide therapeutics for disease treatment. The c...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Parabilis Medicines Analyst Rating
View MoreForecast & Rating
Jul 6, 2026Price forecast
$41.7527.25%
Forecast & RatingStrong buy
5analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · 34 minutes ago
HBM Healthcare swings to CHF 238 million Q1 FY27 profit; NAV per share rises 13%
- Tip Ranks · 1 day ago, 09:01 PM
Major Insider Move Signals Growing Confidence in Parabilis Medicines
- PUBT · 1 day ago, 03:59 PM
RA Capital Management buys USD 6.84 million of Parabilis Medicines common shares
- Global Report · 2 days ago, 04:13 AM
Capital Rotations: A Record Biotech IPO and the Surging European Defense ETF
- Market Beat · Jul 13 at 12:20 AM
Parabilis Medicines, Inc.'s Quiet Period Set To Expire on July 20th (NASDAQ:PBLS)
- benzinga_article · Jul 6 at 06:11 AM
This Parabilis Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
